Kyle A. Fliszar

Experimental Study of Fluidized Bed Co-Granulation of Two Active Pharmaceutical Ingredients: An Industrial Scale-Up Perspective

E. Bilgili, Jeff S. Ko, L. Rosen, 2011 .

Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.

B. Hill, N. Foster, Kyle A. Fliszar, 2007, Journal of pharmaceutical sciences.

Profiling of metal ions leached from pharmaceutical packaging materials.

L. Allain, Kyle A. Fliszar, D. Walker, 2006, PDA journal of pharmaceutical science and technology.

Analysis of organic volatile impurities in pharmaceutical excipients by static headspace capillary gas chromatography.

J. M. Wiggins, Kyle Fliszar, J Mark Wiggins, 2004, Journal of chromatography. A.

Profiling of medium chain glycerides used in pharmaceutical formulation development by reversed-phase HPLC.

R. Reed, W. P. Wuelfing, Kyle A. Fliszar, 2006, Journal of pharmaceutical and biomedical analysis.

Examination of metformin hydrochloride in a continuous dissolution/HDM system.

N. Foster, Kyle A. Fliszar, 2008, International journal of pharmaceutics.

Identification of impurities in ivermectin bulk material by mass spectrometry and NMR.

Andreas M. Abend, R. Reed, T. Hwang, 2006, Journal of pharmaceutical and biomedical analysis.

Effects of Dissolved Gases in Surfactant Dissolution Media

Kyle A. Fliszar, R. Forsyth, Zhong Li, 2005 .

Measurement of Dissolved Oxygen as a Determination of Media Equilibrium During Dissolution Testing

S. Sun, Kyle A. Fliszar, T. Curley, 2004 .